Regeneron Pharmaceuticals, Inc. (REGN)
Market Closed
10 Aug, 20:00
$
808. 05
+23.69
+3.0203%
$
83.25B Market Cap
24.52 P/E Ratio
0.22% Div Yield
981,832 Volume
42.79 Eps
$ 784.36
Previous Close 
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regeneron Pharmaceuticals, Inc. (REGN) Statistics
Valuation metrics
Market Cap 83.25B
Enterprise value 80.34B
Trailing P/E (ttm) 18.73
Forward P/E 12.08
PEG ratio 60.15
Price/Sales (ttm) 5.2
Price/Book (mrq) 2.56
Enterprise Value/Revenue 5.17
Enterprise Value/EBITDA 14.27
Overview
Shares outstanding 105.02M
Float 97.67M
Shares short 3.27M
% Held by insiders 0.02%
% Held by institutions 0.92%
Average volume (10 days) 1.01M
Average volume (90 days) 1M
Price summary
52-Week low 541
52-Week high 821.11
Beta 0.3
50-Day moving average 672.28
200-Day moving average 730.01
Dividends and splits
Forward annual dividend rate 3.76
Forward annual dividend yield 0.0059%
Trailing annual dividend rate 3.64
Trailing annual dividend yield 0.0046%
5-Year annual dividend yield -
Payout ratio 0.09
Dividend Date 4 Jun 2026
Ex-Dividend Date 20 May 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.28%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.14%
Income Statement
Revenue (ttm) 14.92B
Revenue per share (ttm) 150.24
Quarterly revenue growth (yoy) 0.19%
Gross profit (ttm) 6.55B
EBITDA 5.12B
Net income to common (ttm) 4.42B
Diluted EPS (ttm) 41.86
Quarterly earnings growth (yoy) -0.1%
Balance Sheet
Total cash (mrq) 8.75B
Total cash per share (mrq) 77.32
Total debt (mrq) 2.71B
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.34%
Book value per share (mrq) 306.68
Cash Flow
Cash flow statement 5.01B
Levered free cash flow (LFCF) 3.27B
